We seek to provide holistic and thorough solutions that address each of our clients’ needs, while developing the long-term legal precedents that will benefit their portfolio of assets in the future.
The dynamic, complex, and growing field of biotechnology requires unique expertise and long-ranging professional experience to best serve clients in the related areas of patent prosecution and counseling, as well as inter partes matters. As pioneers in the biotech area, Frommer Lawrence & Haug offers unparalleled resources to handle all aspects of intellectual property in this challenging field, whether we are representing educational institutions, governmental bodies, or multinational corporations.
Our work extends across numerous biotech areas, including virology (e.g., poxviruses, baculoviruses, herpesviruses, adenoviruses, retroviruses, virus-like particles, and retrotransposons), immunology (e.g. recombinant virus vaccines, DNA plasmid vaccines, whole attenuated or inactivated vaccines, and subunit vaccines), molecular biology, cellular biology, biomedical engineering, bioinformatics, nucleic acid molecules, proteins (including stem cells and retrodifferentiation), antibodies, recombination techniques, amplification techniques, and genetically engineered animals, cells, viruses, and plants – among others. We focus our efforts on understanding and addressing all client needs and expectations across these sub-fields, regardless of their source.
Our expertise emerges from a uniquely situated group of patent professionals, which includes attorneys, scientists, and patent agents who hold advanced degrees and have gathered broad biotech experience. Many of our attorneys have focused their practice on biotech since the industry’s inception, allowing us to offer clients deep institutional knowledge and a full, detailed treatment of every biotech IP issue brought to our attention.
This knowledge is reflected in all areas of our practice, from the services we provide our clients, to the articles we have published in peer-reviewed journals, to the international biotech conferences in which we participate on an annual basis. Our presence in industry journals and conferences keeps our finger on the pulse of all biotech issues, enabling us to tap the latest, freshest thinking to address our clients’ specific needs. We also maintain an excellent rapport and high credibility with other patent professionals and scientists, as well as the United States Patent and Trademark Office and its examiners. These relationships have greatly augmented the efficiency and success of the patent prosecution for our clients.
Beyond our commitment to excellence and efficiency, we firmly believe that every client should be offered a personal, service-oriented relationship, as well as vigorous representation and protection. We seek to provide holistic and thorough solutions that address each of our clients’ needs, while developing the long-term legal precedents that will benefit their portfolio of assets in the future.
The unusually broad scope of experience within our biotech group, coupled with superior client service, makes our firm a preferred resource to handle any biotechnology intellectual property matter knowledgeably, resourcefully and expertly for our clients.